During the past decade, TIMI Study Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "TIMI Study Group" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "The TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "TIMI Study Group" are "Acute Heart Failure" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Heart Failure" (1 trials), "Myocardial Infarction" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Many other conditions were trialed in "TIMI Study Group" in a lesser frequency.

Most popular intervention types in "TIMI Study Group" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Clopidogrel" (1 trials), "Dapagliflozin" (1 trials) and "Inclisiran" (1 trials). Other intervention names were less common.

The vast majority of trials in "TIMI Study Group" are 3 trials for "All" genders.

Currently, there are NaN active trials in "TIMI Study Group". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in TIMI Study Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in TIMI Study Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".